Interpreting the Benefit and Risk Data in Between-Drug Comparisons: Illustration of the Challenges Using the Example of Mefenamic Acid versus Ibuprofen

por Farkouh, André, Hemetsberger, Margit, Noe, Christian R., Baumgärtel, Christoph
Publicado 2022

Sex-Related Differences in Drugs with Anti-Inflammatory Properties

por Farkouh, André, Baumgärtel, Christoph, Gottardi, Roman, Hemetsberger, Margit, Czejka, Martin, Kautzky-Willer, Alexandra
Publicado 2021

Lipid lowering therapy in primary and secondary prevention in Austria: are LDL-C goals achieved?: Results from the DA VINCI study

por Siostrzonek, Peter, Brath, Helmut, Zweiker, Robert, Drexel, Heinz, Hoelzl, Robert, Hemetsberger, Margit, Ray, Kausik K.
Publicado 2021

Management of secondary hyperparathyroidism: practice patterns and outcomes of cinacalcet treatment with or without active vitamin D in Austria and Switzerland – the observational...

por Pronai, Wolfgang, Rosenkranz, Alexander R., Bock, Andreas, Klauser-Braun, Renate, Jäger, Christine, Pendl, Gunther, Hemetsberger, Margit, Lhotta, Karl
Publicado 2017

Characteristics and outcomes of patients with psoriasis treated with apremilast in the real-world in Austria – results the APPRECIATE study

por Jonak, Constanze, Göttfried, Isolde, Perl-Convalexius, Sylvia, Gruber, Barbara, Schütz-Bergmayr, Martina, Vujic, Igor, Weger, Wolfgang, Schicher, Nikolaus, Semlin, Lydia, Hemetsberger, Margit, Cordey, Myriam, Sator, Paul
Publicado 2023